semaglutide · Novo Nordisk
What should I know about Wegovy?
Wegovy by Novo Nordisk: Weight, heart, MASH · pen and pill. Cost, side effects, dosing as labeled, comparisons and the latest news, all sourced.
Start hereWegovy FAQ: What People Ask Before and After StartingAnswers to the most-searched Wegovy questions in 2026, including the pill, the 7.2 mg HD dose, what it costs, why insurance dropped it, how much weight people lose and what happens when you stop.
FAQ
Semaglutide FAQ: 50 Questions People Ask GooglePlain-English answers to the 50 questions Americans most often type into Google about semaglutide, from what it is and how much it costs to what happens when you stop.Zepbound: 50 Questions People Ask GoogleThe fifty questions Americans actually type into Google about Zepbound, answered from the FDA label, Eli Lilly's own pricing pages and the 2026 approvals — including the sleep apnea indication no other drug has, the three savings offers people confuse, the 45-day refill rule that can add $250 a month, and what the KwikPen changed.
How-to guides
At the Pharmacy Counter: Savings Cards, NDCs and Mail-Order for GLP-1sA savings card is a second insurance claim, not a coupon. Here is the processing code your pharmacist actually needs, how to read the NDC to confirm you got the right dose and device, and how the two manufacturer mail-order channels work.How to Inject Wegovy, Exactly as the FDA-Approved Instructions Describe ItWegovy now comes in four different injection devices, and they do not work the same way. Here is what each FDA-approved Instructions for Use actually says about priming, pinching, holding, and knowing the dose went in.How to Store GLP-1 Pens: The Full Table, Plus Travel and HeatThere are at least seven different out-of-fridge windows across the GLP-1 products sold in the US, ranging from 21 days to 56 days, and two products that never need a fridge at all. Here is every rule, from the labels, in one place.How to Take a GLP-1 Pill: Rybelsus, the Wegovy Pill and Foundayo ComparedOral semaglutide has a strict morning ritual: empty stomach, four ounces of water, thirty minutes of nothing. Foundayo has none of it. Here is exactly what each label requires and why the difference exists.Missed a Dose of Ozempic, Wegovy, Mounjaro or Zepbound? What the Labels SayEvery GLP-1 has a different missed-dose rule, and two of them are written backward from each other. Here is what each FDA-approved label actually says, for nine drugs, in one table.
Side effects & safety
Can You Drink Alcohol on Semaglutide?There is no alcohol warning on the semaglutide label, but there are three real reasons drinking feels different on this drug, and two randomized trials now show it changes how much people drink.Does Semaglutide Cause Muscle Loss?Some of the weight lost on semaglutide is lean tissue, which is true of nearly all weight loss, but the size of that share and what changes it are the parts worth understanding.How to Manage Nausea on Semaglutide: What the Research and Labels SayNausea hits nearly half the people who start semaglutide at the weight-management dose, and the label itself explains why the dose schedule exists and what to do when a step up does not go well.Semaglutide and Surgery: The Anesthesia QuestionAnesthesiologists spent two years arguing about whether to stop GLP-1 drugs before surgery, and the guidance has now flipped once, so here is what the label, the societies and the trials actually say.Semaglutide Side Effects: The Complete List With How Common Each One IsA plain-English walkthrough of every semaglutide side effect that appears in the FDA labels for Ozempic, Wegovy and Rybelsus, with the actual trial percentages next to each one.Tirzepatide vs Semaglutide Side Effects: What the Head-to-Head Evidence ShowsA direct comparison of Zepbound and Mounjaro against Wegovy and Ozempic on side effects, using the one randomized head-to-head trial, the best observational study, and the differences written into the two labels.
Stopping & switching
Coming Off Compounded Semaglutide: How the Transition WorksCompounded semaglutide is winding down. Moving to an FDA-approved product means a new prescription, a dose your prescriber has to map by hand, and no overlap between products. Here is how the transition works and what to bring to the appointment.Do You Have to Take Wegovy Forever?The label sets no stop date and obesity societies now strongly recommend continuing during maintenance - but two 2026 trials changed the question from whether to stop to whether you can use less.GLP-1 Maintenance Dose: What the Research SaysTwo 2026 randomized trials finally tested whether you can hold weight loss on less drug. Here is what they found, what the labels allow, and why 'microdosing' is still a marketing term rather than a protocol.Switching From Wegovy to Zepbound: What to KnowThere is no FDA-approved dose conversion between semaglutide and tirzepatide. Here is what the labels actually say, what published switching data shows, and the questions worth asking before your first Zepbound dose.
Compounded & telehealth
Compounded vs Brand-Name Semaglutide: Cost and DifferencesCompounded semaglutide once cost a fraction of Wegovy, but branded self-pay prices fell hard in late 2025 and 2026, and the gap is now small enough that the two are worth comparing on total cost, not sticker price.How to Spot Counterfeit OzempicCounterfeit Ozempic pens have reached the legitimate U.S. supply chain three separate times, and the fastest way to check yours is where the EXP/LOT text sits on the pen label.
Alternatives
Contrave vs Wegovy: Which Weight Loss Drug Fits Which Person?Contrave is an oral pill aimed at cravings and food reward. Wegovy is a weekly injection that produces roughly three times more weight loss. Contrave can cost as little as $20 a month with a copay card. Here is the full comparison, including the boxed warning most people do not know about.Phentermine vs GLP-1s: Cost, Results and Who Each One SuitsPhentermine costs about $14 to $41 a month and has been on the market since 1959. Wegovy and Zepbound cost $299 to $449 and produce three to five times more weight loss. Here is the real comparison, including the label limits most articles skip.
Results & daily life
Daily Life on a GLP-1: Work, Travel, Tracking and the Stuff Nobody Warns You AboutThe practical side of living on semaglutide or tirzepatide: dose day and work, travel and storage rules from the labels, tracking apps and what the research says about them, non-scale victories, stigma at work, and the daily-life questions nobody has studied yet.Exercise on GLP-1s: What the Evidence Actually ShowsStrength training and cardio while taking semaglutide or tirzepatide: what randomized trials, meta-analyses and society guidance say about muscle, results, and what happens after the drug stops — plus an honest map of what has never been tested.GLP-1 Plateau: Why Weight Loss Stalls and What the Research SaysPlateaus on semaglutide and tirzepatide are expected, measurable and well described in the trial data. Here is how researchers define a plateau, when it typically arrives, why it happens, and what the studies say about what comes next.How Fast Does Semaglutide Work? A Week-by-Week Reality CheckWhat the FDA label and the STEP trials actually show about how quickly semaglutide works, month by month — including the five-month milestone, when the curve flattens, and why real-world results run lower.How Fast Does Zepbound Work? What the Trial Curves ShowA month-by-month look at tirzepatide's weight-loss curve from SURMOUNT-1 and the FDA label — when the dose is reached, when most of the loss happens, when people plateau, and what happens to late responders.How Much Protein on a GLP-1? What Dietitians and the Research SayProtein targets on semaglutide and tirzepatide, where the numbers come from, why per-kilogram advice is confusing, what the body-composition data actually shows, and why protein alone will not do the job.
Getting started
Do I Qualify for Wegovy, Zepbound or Another GLP-1?A plain-English walk through who each FDA-approved GLP-1 is actually labeled for, where the BMI 30 and BMI 27 rules come from, what counts as a weight-related condition, and why your insurance plan may use stricter rules than the FDA label.How to Find an Obesity Medicine DoctorWhat obesity medicine certification actually means, the two free directories that list certified clinicians, how to verify a credential yourself, what these visits cost, and when a specialist is worth the extra step versus staying with primary care.How to Get a GLP-1 Prescription: Every Legitimate RouteThe six real ways to get an FDA-approved GLP-1 prescription in the US, what each one costs in time and money, what the FDA says about the sellers you should avoid, and how to verify anyone before you hand over a card number.Questions to Ask Your Doctor About GLP-1 MedicationThirty-one questions worth asking before and after you start a GLP-1, each one tied to something a specific FDA label, guideline recommendation or federal rule actually says, plus what a good answer sounds like.What to Expect Your First Month on a GLP-1Week by week through the starting dose, why it is deliberately too low to be a treatment dose, the side effect rates recorded in trials, the missed-dose rules that differ by product, and what the labels say should prompt a call to your clinician.Which GLP-1 Is Right for Me? How Doctors DecideWhat the guidelines actually say about choosing between semaglutide, tirzepatide, orforglipron and liraglutide, plus the seven practical factors that usually settle it, including the one clinicians rarely say out loud.
Cost & insurance
Does Insurance Cover Wegovy? How to Check and How to AppealWhether Wegovy is covered depends almost entirely on what kind of plan you have, and this guide walks through how to check your specific coverage and what to do step by step if you are denied.Does Medicare Cover Wegovy or Ozempic?Medicare Part D can cover semaglutide for diabetes, heart disease and kidney disease, and since July 1, 2026 a temporary program called the Medicare GLP-1 Bridge covers Wegovy for obesity at a flat $50 a month through the end of 2027.How Much Does Semaglutide Cost Without Insurance in 2026?Without insurance, brand-name semaglutide now runs about $149 to $499 a month depending on which product and dose you take, far below the $1,027 to $1,349 list prices.Ozempic Savings Card and Coupons ExplainedThe Ozempic and Wegovy savings cards cut your copay to as little as $25 a month if you have commercial insurance that covers the drug, but they help with no more than $100 a month and are useless if you are uninsured or on Medicare.The Cheapest Way to Get Semaglutide Legally: Every Option ComparedEight legal routes to semaglutide in 2026, ranked by what you actually pay, from a $25 copay with good insurance down to the $149 pill and up to the $1,349 list price.
Medications
Every FDA-Approved GLP-1 Medication (2026 List)A complete, sourced list of every GLP-1 receptor agonist medication approved and sold in the United States as of September 2026, including what each one treats, what it costs and which ones have been discontinued.How to Store and Use a Semaglutide Pen (From the Label)What the FDA-approved labels actually say about refrigerating, warming, injecting, disposing of and spotting counterfeit Ozempic and Wegovy pens.Ozempic vs Wegovy vs Rybelsus: What's the Difference?Ozempic, Wegovy and Rybelsus all contain semaglutide, but they carry different FDA-approved uses, different doses and very different prices - and in 2026 Rybelsus was rebranded as the Ozempic pill.Wegovy Pill: Everything We KnowThe Wegovy pill is FDA-approved oral semaglutide 25 mg for weight management - here is what the label says about doses, how to take it, how much weight people lost in trials, and what it costs.Wegovy vs Zepbound: Which Weight-Loss Shot Does What?Wegovy and Zepbound are the two leading FDA-approved weekly injections for weight management - they use different molecules, carry different extra indications, come in different devices and are priced very differently.
Pipeline
Every GLP-1 Drug in Development, Ranked by How Close It Is to ApprovalMore than 25 weight-loss drugs are in late-stage development. This ranks them by one thing only: how close each is to an FDA decision, based on filing status and clinical trial registry dates as of September 14, 2026. One is under review right now. Most will not reach a pharmacy before 2029.Lilly vs. Novo Nordisk: The Obesity Drug War, ExplainedHow Eli Lilly overtook Novo Nordisk in the US weight-loss market, where Novo is still winning, and what the rivalry means for what you pay and what you can get.Orforglipron (Foundayo): The GLP-1 Pill, ExplainedWhat orforglipron is, how much weight people lost in the trials, what it costs, and how it differs from the Wegovy pill and from injections like Wegovy and Zepbound.Survodutide: What to Know About Boehringer's Glucagon Weight-Loss DrugSurvodutide lost less weight than retatrutide or tirzepatide in its pivotal trial, but it cut liver fat by about 63% and visceral fat by about 34%. Here is what the SYNCHRONIZE trials actually showed, why the FDA gave it breakthrough status for liver disease, when it might be filed, and which survodutide trials are still open.When Will Generic Ozempic Be Available in the US?Generic semaglutide is already on sale in India and Canada, but the US patent situation pushes an American generic to the end of 2031 at the earliest. Here is the timeline and what is available in the meantime.
Foundayo
Specific groups
GLP-1 Drugs and Men's Health: Testosterone, Sex, Muscle and ResultsMen lose less percentage weight than women on the same dose, their testosterone tends to rise as they lose weight, the erectile function evidence points in two directions at once, and the muscle question is real. Here is what the 2025-2026 research actually found.GLP-1 Drugs for Teens: What Parents Should Know in 2026Two GLP-1 medicines are FDA-approved for adolescents with obesity, one is approved for children as young as 10 with type 2 diabetes, and none are approved under 12 for weight. Here is what the trials found, what the American Academy of Pediatrics guideline says, and what questions are still genuinely open.GLP-1s After Bariatric Surgery: What the Evidence Says in 2026Weight coming back after gastric sleeve or bypass is common, and adding semaglutide or tirzepatide is now one of the most-studied responses to it. A 2026 randomized trial and a 208,000-patient US cohort finally give real numbers - here is what they found, and what nobody has tested yet.GLP-1s and Menopause: What the Research Actually ShowsMenopause changes where your body stores fat and how much energy you burn, and GLP-1 drugs work in perimenopausal and postmenopausal women about as well as they work in younger women. The newer and more interesting question is whether menopause hormone therapy makes them work even better - here is what the evidence says, and what it does not say.GLP-1s for Type 1 Diabetes: What the Research Shows in 2026No GLP-1 or dual incretin drug is approved for type 1 diabetes anywhere, and the Wegovy label says use in type 1 diabetes has not been evaluated. But a randomized trial, a Danish national cohort and UK real-world data now exist - and they say something more specific than 'off-label.'GLP-1s Over 65: What the Data Actually ShowsNo GLP-1 label sets an age limit or an age-based dose, and trial analyses in adults 65 and older find efficacy close to younger adults. The real differences are tolerability, muscle and function, one specific fracture observation in the Wegovy label, and the fact that Medicare will not pay for weight loss.Who Should Not Take GLP-1 Drugs, According to the LabelsThe FDA labels for Wegovy, Ozempic, Zepbound and Mounjaro list exactly two absolute contraindications each. Everything else - pancreatitis, gallbladder disease, gastroparesis, pregnancy, surgery, eye disease - sits in warnings, 'not recommended' statements, and gaps where nobody has studied the question at all. Here is the actual list.
Market & policy
GLP-1 Prescriptions in the US: The Numbers by QuarterHow many GLP-1 prescriptions Americans actually fill, quarter by quarter and week by week, plus the revenue those prescriptions generate for Novo Nordisk and Eli Lilly, and why the published numbers disagree with each other.How Employers Are Handling GLP-1 CostsEmployer coverage of GLP-1s for weight loss peaked and is now shrinking. Here is what the 2026 and 2027 benefits surveys say, what employers are doing instead of dropping coverage outright, and what it means if your plan changes.State Medicaid and GLP-1s: Who Covers WhatOnly 13 state Medicaid programs covered GLP-1s for obesity as of January 2026, down from 16 the previous fall. Here is which states dropped coverage, why, what is still required by federal law, and what the CMS BALANCE model was supposed to change.The GLP-1 Patent Cliff: What Happens in 2031 and 2032Semaglutide's main US compound patent expires December 5, 2031, tirzepatide's January 5, 2036. Here is what that actually means for prices, which patents could delay generics, and why the rest of the world already has cheap semaglutide.Where Americans Actually Buy GLP-1s NowThe GLP-1 prescription moved out of the insurance benefit and into the checkout line. Here is how the cash-pay channel works, what each retailer and telehealth platform charges, and what the shift means for your pharmacy record.
Insurance navigation
GLP-1 Prior Authorization: What Insurers Actually RequireWhat the published prior authorization criteria from UnitedHealthcare, CVS Caremark, Aetna, Cigna, Express Scripts and BCBS FEP actually say about BMI, comorbidities, lifestyle programs, step therapy, quantity limits and renewals — with the documents quoted and linked.How to Appeal a GLP-1 DenialHow to read a denial letter, tell an exclusion from a medical necessity denial, work through internal appeals, and use your right to an independent external review — with deadlines, required notice contents, and what the data says about your odds.How to Get Wegovy or Zepbound Covered by InsuranceA step-by-step process for finding out whether your plan covers a GLP-1 for weight loss, what it will require, and what to do at each fork in the road — written for the person holding the insurance card, not the prescription pad.HSA and FSA for GLP-1 DrugsWhether you can pay for Wegovy, Zepbound, Ozempic or a compounded GLP-1 with tax-free HSA or FSA money, when a letter of medical necessity is needed, what the tax deduction really requires, and how to work out whether to run a fill through insurance or pay cash.Medicaid Coverage of GLP-1s by StateWhich state Medicaid programs cover GLP-1s for obesity, which coverage is required in every state no matter what, what changed in 2025 and 2026, and how to check your own state's rules — plus how ACA Marketplace coverage compares.Medicare GLP-1 Bridge: How It WorksThe step-by-step mechanics of Medicare's GLP-1 Bridge demonstration: who qualifies, which products and devices are covered, how the prescription and prior authorization must be sequenced, what the $50 copay does and does not count toward, and why there is no appeal.Novo Nordisk and Lilly Patient Assistance Programs ExplainedWho actually qualifies for the Novo Nordisk Patient Assistance Program and the Lilly Cares Foundation, what the savings cards really cap out at, why a $25 card can turn into a $500 bill in month six, and how copay accumulators and alternative funding programs change the picture.Which Employers Cover GLP-1s?What the 2025 and 2026 employer surveys actually show about GLP-1 coverage, why the numbers disagree with each other, the strings employers attach, which state and federal plans cover the drugs, and how to find out what your own employer does.
How they work
How Does Semaglutide Work? The Mechanism, Explained SimplySemaglutide is a lab-modified copy of a gut hormone that tells your pancreas to release insulin, tells your liver to hold back sugar, slows your stomach, and signals fullness to your brain - and the modifications let one dose last about a week.How Does Zepbound Work? GIP and GLP-1 ExplainedZepbound is tirzepatide, the same molecule as Mounjaro, approved for weight management and sleep apnea. It activates two gut hormone receptors - GIP and GLP-1 - and this guide explains what each one does to appetite, fat tissue and the brain.How Long Does Semaglutide Stay in Your System?The FDA label answers this directly: with a half-life of about one week, semaglutide stays in your circulation for roughly five weeks after your last dose - which shapes everything from side effects to surgery to pregnancy planning.Oral vs Injectable Semaglutide: What's the Difference in 2026?Same molecule, three US brand names across five presentations, two completely different journeys into the bloodstream - and a 2026 rebranding that means Ozempic now comes as both a pen and a pill that are not interchangeable.Semaglutide vs Tirzepatide: How the Two Drugs Actually DifferSemaglutide hits one receptor, tirzepatide hits two - and in the only head-to-head trial, tirzepatide produced more weight loss, though the two molecules differ in more ways than a single number captures.
Clinical trials
How Much Weight Do People Lose on Semaglutide? The Numbers From Every Major TrialTrial-by-trial weight-loss figures for every semaglutide dose and formulation, plus why real-world results usually land lower.How Much Weight Do People Lose on Zepbound? The Numbers From Every TrialEvery published tirzepatide weight-loss figure in one place — by dose, by population, by trial, and by how it was measured — plus what the same drug does outside of a clinical trial.SELECT Trial Explained: Semaglutide and Heart HealthThe SELECT trial followed 17,604 people with heart disease and excess weight for about four years and found semaglutide cut major cardiac events by 20% — here is what that number means and what it does not.Semaglutide vs Tirzepatide Head to Head: What SURMOUNT-5 FoundSURMOUNT-5 is the only large randomized trial that pitted tirzepatide directly against semaglutide at obesity doses — here are the numbers, the caveats, and what the trial could not measure.What Happens When You Stop Taking SemaglutideTrial data shows most people regain about two-thirds of lost weight within a year of stopping semaglutide, and blood pressure, cholesterol and blood sugar drift back toward baseline.
Culture
FDA & regulation
Is Semaglutide Still in Shortage? What the FDA List Says in 2026The FDA declared the semaglutide injection shortage resolved on February 21, 2025, and it has not returned since, which is why compounded copies of Ozempic and Wegovy are no longer generally legal.Semaglutide Approvals by Country: Where Ozempic and Wegovy Are ApprovedA country-by-country guide to semaglutide approvals, from the US and EU to Canada's first-in-the-G7 generics, plus where the Wegovy pill is available and where the labels disagree.The Complete FDA Approval History of Semaglutide (2017-2026)Every FDA approval, new indication and major label change for semaglutide from the first Ozempic approval in December 2017 through the Wegovy pill, Wegovy HD 7.2 mg and the Ozempic tablets rebrand in 2026.
Companies
Novo Nordisk's Pipeline: What Comes After WegovyA plain-English guide to what Novo Nordisk is working on next — CagriSema, zenagamtide, cagrilintide, the oral pills already on the market, and the trials that failed along the way.Who Makes Ozempic? Novo Nordisk ExplainedOzempic, Wegovy and the Ozempic pill are all made by Novo Nordisk, a 100-year-old Danish company controlled by a charitable foundation — here is how it works, where the drugs are made, and how much money it brings in.
Liraglutide
Saxenda vs Wegovy: How the Daily and Weekly Shots Really CompareSaxenda is daily liraglutide; Wegovy is weekly semaglutide. A head-to-head trial put average weight loss at 6.4% versus 15.8%. Here is what that means in practice, plus cost, side effects, and why Saxenda is being discontinued in 2027.Switching From Liraglutide to a Weekly GLP-1: What the Labels Actually SayThere is no official conversion chart from Saxenda or Victoza to Wegovy, Ozempic or Zepbound. Here is what the FDA labels do say about starting doses, overlapping GLP-1 drugs and shortages, plus the one study that tested a direct switch.
News
Semaglutide: A Year-by-Year HistoryA plain-English timeline of semaglutide from its 2017 approval as Ozempic through the Wegovy pill, the price collapse and the 2026 patent cliff.The Biggest GLP-1 Stories of 2025The ten developments that reshaped semaglutide and the wider GLP-1 market in 2025, from the end of the shortage to the first GLP-1 pill for weight loss.The Biggest GLP-1 Stories of 2026 So FarFrom the Wegovy pill launch to Medicare's $50 copay and the March patent cliff, the developments that have defined the GLP-1 market through September 2026.What to Watch Next in GLP-1 NewsThe decisions, trials, court dates and price changes coming between late 2026 and 2028 that will shape what semaglutide costs and who can get it.
Beyond weight loss
Recent Wegovy news
Full timeline- Prices
Status check: Novo Nordisk's $675 list price still lands well above every negotiated and cash price
- Prices
Status check: the Zepbound formulary class action against CVS Caremark remains live as restoration nears
- Compounding
Branded tirzepatide self-pay prices sit far below the shortage-era gap
- Competition
Novo's Wegovy pill still outruns Foundayo roughly four to one
- Competition
Wegovy pill and Foundayo both hit record weekly prescriptions
- FDA & regulation
China approves Wegovy for MASH, the first GLP-1 cleared for the liver disease there
- Research
Comparative review: tirzepatide wins on weight, not on tolerability